Vascularised Brain Organoids: Engineering Strategies and Neurobiological Applications

Abstract

Brain organoids have become an essential platform for studying human neural development and neurological disorders. Yet, one major limitation of conventional brain organoids is their lack of vascular structures. This deficiency restricts organoid size, contributes to necrotic core formation, and hampers their functional maturation. Introducing vascularization offers a compelling solution—it enhances nutrient delivery, supports neurogenesis, and fosters the development of interfaces that resemble the blood–brain barrier (BBB). In this review, we explore how vascularization enhances the structural and physiological relevance of brain organoids and its growing significance in disease modelling and therapeutic screening. We examine current methodologies for engineering vascularized brain organoids (vBOs), including co-culturing with endothelial cells (ECs), transcriptional programming, tissue fusion techniques, microfluidic perfusion systems, and 3D bioprinting. These strategies vary in complexity, scalability, and the extent to which they achieve vascular integration. Functionally, vBOs demonstrate improved oxygen diffusion, enhanced synaptic development, and more robust barrier properties. Such advances enable modelling of complex neurovascular conditions like stroke, glioblastoma, and BBB dysfunction. Moreover, vBOs are emerging as valuable tools in developmental studies and personalised medicine, supporting patient-derived modelling and large-scale drug testing in BBB-relevant contexts. Despite these advances, replicating the structural complexity, functionality, and long-term stability of native vasculature remains challenging. We discuss current limitations and highlight innovative approaches, including the use of next-generation biomaterials and dynamic perfusion technologies. Ultimately, vBOs mark a significant step towards creating physiologically accurate in vitro models of the human brain—offering new opportunities for neuroscience research, drug development, and regenerative medicine.

Keywords

blood–brain barrier (BBB) / neurovascular disease modelling / perfusion and microfluidic systems / regenerative medicine and cell therapy / vascularized brain organoids

References

[1] C. T. Lee, R. M. Bendriem, W. W. Wu, and R. F. Shen, “3D Brain Organoids Derived From Pluripotent Stem Cells: Promising Experimental Models for Brain Development and Neurodegenerative Disorders,” Journal of Biomedical Science 24, no. 1 (2017): 59.

[2] S. Park and J.-C. Park, “Advancements in Brain Organoid Models for Neurodegenerative Disease Research,” Organoid 4 (2024): 4.

[3] A. K. Beutel, M. Ekizce, T. J. Ettrich, et al., “Organoid-Based Precision Medicine in Pancreatic Cancer,” United European Gastroenterology Journal 13, no. 1 (2025): 21–33.

[4] S. P. Harrison, R. Siller, Y. Tanaka, et al., “Scalable Production of Tissue-Like Vascularized Liver Organoids From Human PSCs,” Experimental & Molecular Medicine 55, no. 9 (2023): 2005–2024.

[5] N. Gupta, T. Matsumoto, K. Hiratsuka, et al., “Modeling Injury and Repair in Kidney Organoids Reveals That Homologous Recombination Governs Tubular Intrinsic Repair,” Science Translational Medicine 14, no. 634 (2022): eabj4772.

[6] A. Boilève, J. Cartry, N. Goudarzi, et al., “Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer,” Gastroenterology 167, no. 5 (2024): 961–976.e913.

[7] H. J. Kim, G. Kim, K. Y. Chi, et al., “Generation of Multilineage Liver Organoids With Luminal Vasculature and Bile Ducts From Human Pluripotent Stem Cells via Modulation of Notch Signaling,” Stem Cell Research & Therapy 14, no. 1 (2023): 19.

[8] S. S. Lee, X. Du, I. Kim, and S. J. Ferguson, “Scaffolds for Bone-Tissue Engineering,” Matter 5, no. 9 (2022): 2722–2759.

[9] I. Kim, S. S. Lee, A. Ghosh, S. J. Ferguson, and O. Bar-Nur, “A Self-Renewing Biomimetic Skeletal Muscle Construct Engineered Using Induced Myogenic Progenitor Cells,” Advanced Functional Materials 34, no. 1 (2024): 2300571.

[10] L. Moreira, B. Bakir, P. Chatterji, Z. Dantes, M. Reichert, and A. K. Rustgi, “Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer,” Cellular and Molecular Gastroenterology and Hepatology 5, no. 3 (2018): 289–298.

[11] T. Takebe, K. Sekine, M. Enomura, et al., “Vascularized and Functional Human Liver From an iPSC-Derived Organ Bud Transplant,” Nature 499, no. 7459 (2013): 481–484.

[12] R. Morizane, A. Q. Lam, B. S. Freedman, S. Kishi, M. T. Valerius, and J. V. Bonventre, “Nephron Organoids Derived From Human Pluripotent Stem Cells Model Kidney Development and Injury,” Nature Biotechnology 33, no. 11 (2015): 1193–1200.

[13] S. F. Boj, C. I. Hwang, L. A. Baker, et al., “Organoid Models of Human and Mouse Ductal Pancreatic Cancer,” Cell 160, no. 1–2 (2015): 324–338.

[14] M. Huch, H. Gehart, R. van Boxtel, et al., “Long-Term Culture of Genome-Stable Bipotent Stem Cells From Adult Human Liver,” Cell 160, no. 1–2 (2015): 299–312.

[15] A. D. Rubio, L. Hamilton, M. Bausch, et al., “A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders,” Journal of Neuroimmune Pharmacology 20, no. 1 (2025): 23.

[16] M. A. Lancaster, M. Renner, C. A. Martin, et al., “Cerebral Organoids Model Human Brain Development and Microcephaly,” Nature 501, no. 7467 (2013): 373–379.

[17] Q.-J. Mei, J.-Q. Wen, X.-X. Xu, and H.-Q. Xie, “Generation of Vascularized Brain Organoids: Technology, Applications, and Prospects,” Organoid Research 1, no. 2 (2025): 8162.

[18] B. Cakir, Y. Xiang, Y. Tanaka, et al., “Engineering of Human Brain Organoids With a Functional Vascular-Like System,” Nature Methods 16, no. 11 (2019): 1169–1175.

[19] M. T. Pham, K. M. Pollock, M. D. Rose, et al., “Generation of Human Vascularized Brain Organoids,” NeuroReport 29, no. 7 (2018): 588–593.

[20] M. P. Schwartz, Z. Hou, N. E. Propson, et al., “Human Pluripotent Stem Cell-Derived Neural Constructs for Predicting Neural Toxicity,” Proceedings of the National Academy of Sciences of the United States of America 112, no. 40 (2015): 12516–12521.

[21] H. Naderi-Meshkin, V. A. Cornelius, M. Eleftheriadou, K. N. Potel, W. A. W. Setyaningsih, and A. Margariti, “Vascular Organoids: Unveiling Advantages, Applications, Challenges, and Disease Modelling Strategies,” Stem Cell Research & Therapy 14, no. 1 (2023): 292.

[22] T. M. Kim, R. H. Lee, M. S. Kim, C. A. Lewis, and C. Park, “ETV2/ER71, the Key Factor Leading the Paths to Vascular Regeneration and Angiogenic Reprogramming,” Stem Cell Research & Therapy 14, no. 1 (2023): 41.

[23] C. J. Kirkpatrick, S. Fuchs, and R. E. Unger, “Co-Culture Systems for Vascularization—Learning From Nature,” Advanced Drug Delivery Reviews 63, no. 4–5 (2011): 291–299.

[24] Y.-P. Shen and Z. Kokaia, “Brain Organoid Transplantation: A Comprehensive Guide to the Latest Advances and Practical Applications—A Systematic Review,” Cells 14, no. 14 (2025): 1074.

[25] M. Rizzuti, V. Melzi, L. Brambilla, et al., “Shaping the Neurovascular Unit Exploiting Human Brain Organoids,” Molecular Neurobiology 61, no. 9 (2024): 6642–6657.

[26] A. A. Mansour, J. T. Gonçalves, C. W. Bloyd, et al., “An In Vivo Model of Functional and Vascularized Human Brain Organoids,” Nature Biotechnology 36, no. 5 (2018): 432–441.

[27] C. Quintard, E. Tubbs, G. Jonsson, et al., “A Microfluidic Platform Integrating Functional Vascularized Organoids-On-Chip,” Nature Communications 15, no. 1 (2024): 1452.

[28] J. Vetter, I. Palagi, A. Waisman, and A. Blaeser, “Recent Advances in Blood-Brain Barrier-On-a-Chip Models,” Acta Biomaterialia 197 (2025): 1–28.

[29] L. Kistemaker, E. J. van Bodegraven, H. E. de Vries, and E. M. Hol, “Vascularized Human Brain Organoids: Current Possibilities and Prospects,” Trends in Biotechnology 43, no. 6 (2025): 1275–1285.

[30] Y. Uchida, S. Ohtsuki, Y. Katsukura, et al., “Quantitative Targeted Absolute Proteomics of Human Blood-Brain Barrier Transporters and Receptors,” Journal of Neurochemistry 117, no. 2 (2011): 333–345.

[31] M.-P. Dehouck, M. Tachikawa, Y. Hoshi, et al., “Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived From Hematopoietic Stem Cells,” Cells 11, no. 24 (2022): 3963.

[32] T. J. Dause, J. K. Denninger, R. Osap, A. E. Walters, J. D. Rieskamp, and E. D. Kirby, “Autocrine VEGF Drives Neural Stem Cell Proximity to the Adult Hippocampus Vascular Niche,” Life Science Alliance 7, no. 7 (2024): e202402659.

[33] Q. Yao, S. Cheng, Q. Pan, et al., “Organoids: Development and Applications in Disease Models, Drug Discovery, Precision Medicine, and Regenerative Medicine,” MedComm 5, no. 10 (2024): e735.

[34] J. Huang, Y. Zhu, J. Tang, et al., “Navigating Brain Organoid Maturation: From Benchmarking Frameworks to Multimodal Bioengineering Strategies,” Biomolecules 15, no. 8 (2025): 1118.

[35] C. Boncristiani, A. Di Gilio, F. De Castro, et al., “Recent Advances in Multicellular Spheroid Models for Multiparametric Blood-Brain Barrier Detection in Microfluidic Systems,” Journal of Materials Chemistry B 13 (2025): 6597–6625.

[36] G. G. da Silva, D. P. Sacomani, B. G. de Carvalho, et al., “Microfluidic Systems to Mimic the Blood–Brain Barrier: From Market to Engineering Challenges and Perspectives,” ACS Biomaterials Science & Engineering 11 (2025): 3789–3815.

[37] J. J. Kim and D.-W. Cho, “Advanced Strategies in 3D Bioprinting for Vascular Tissue Engineering and Disease Modelling Using Smart Bioinks,” Virtual and Physical Prototyping 19, no. 1 (2024): e2395470.

[38] F. Maggiotto, L. Bova, S. Micheli, et al., “3D Bioprinting for the Production of a Perfusable Vascularized Model of a Cancer Niche,” Frontiers in Bioengineering and Biotechnology 13 (2025): 1484738.

[39] A. Shin, J. R. Ryu, B. G. Kim, and W. Sun, “Establishment and Validation of a Model for Fetal Neural Ischemia Using Necrotic Core-Free Human Spinal Cord Organoids,” Stem Cells Translational Medicine 13, no. 3 (2024): 268–277.

[40] C. Wang, M. Sun, C. Shao, et al., “A Multidimensional Atlas of Human Glioblastoma-Like Organoids Reveals Highly Coordinated Molecular Networks and Effective Drugs,” npj Precision Oncology 8, no. 1 (2024): 19.

[41] L. Begani, L. G. Remore, S. Ragosta, et al., “Modeling Glioblastoma With Brain Organoids: New Frontiers in Oncology and Space Research,” International Journal of Molecular Sciences 26 (2025): 10664.

[42] C. Dolciotti, M. Righi, E. Grecu, et al., “The Translational Power of Alzheimer's-Based Organoid Models in Personalized Medicine: An Integrated Biological and Digital Approach Embodying Patient Clinical History,” Frontiers in Cellular Neuroscience 19 (2025): 1553642.

[43] N. Dupré, A. Drieu, and A. Joutel, “Pathophysiology of Cerebral Small Vessel Disease: A Journey Through Recent Discoveries,” Journal of Clinical Investigation 134, no. 10 (2024): e172841.

[44] Y. Yang, C. Deng, F. Aldali, et al., “Therapeutic Approaches and Potential Mechanisms of Small Extracellular Vesicles in Treating Vascular Dementia,” Cells 14, no. 6 (2025): 409.

[45] M. B. Simões-Abade, M. Patterer, A. M. Nicaise, and S. Pluchino, “Brain Organoid Methodologies to Explore Mechanisms of Disease in Progressive Multiple Sclerosis,” Frontiers in Cellular Neuroscience 18 (2024): 1488691.

[46] J. M. Pasquini and J. D. Correale, “The Immunological Role of Oligodendrocytes: Beyond Myelin Maintenance,” Discovery Immunology 4, no. 1 (2025): kyaf005.

[47] N. Daviaud, R. H. Friedel, and H. Zou, “Vascularization and Engraftment of Transplanted Human Cerebral Organoids in Mouse Cortex,” eNeuro 5, no. 6 (2018): ENEURO.0219–ENEU18.2018.

[48] Y. Soliman, J. Al-khodor, G. Yildirim Köken, and N. Mustafaoglu, “A guide for blood–brain barrier models,” FEBS Letters 599, no. 5 (2025): 599–644.

[49] S. M. Boutom, T. P. Silva, S. P. Palecek, E. V. Shusta, T. G. Fernandes, and R. S. Ashton, “Central Nervous System Vascularization in Human Embryos and Neural Organoids,” Cell Reports 43, no. 12 (2024): 115068.

[50] Y. Zhang, X. Shen, S. Deng, Q. Chen, and B. Xu, “Neural Regulation of Vascular Development: Molecular Mechanisms and Interactions,” Biomolecules 14, no. 8 (2024): 966.

[51] S. Bergmann, S. E. Lawler, Y. Qu, et al., “Blood-Brain-Barrier Organoids for Investigating the Permeability of CNS Therapeutics,” Nature Protocols 13, no. 12 (2018): 2827–2843.

[52] H. Kurz, “Cell Lineages and Early Patterns of Embryonic CNS Vascularization,” Cell Adhesion & Migration 3, no. 2 (2009): 205–210.

[53] I. Paredes, P. Himmels, and C. Ruiz de Almodóvar, “Neurovascular Communication During CNS Development,” Developmental Cell 45, no. 1 (2018): 10–32.

[54] J. Kim, B. K. Koo, and J. A. Knoblich, “Human Organoids: Model Systems for Human Biology and Medicine,” Nature Reviews. Molecular Cell Biology 21, no. 10 (2020): 571–584.

[55] V. Llorente, P. Velarde, M. Desco, and M. V. Gómez-Gaviro, “Current Understanding of the Neural Stem Cell Niches,” Cells 11, no. 19 (2022): 3002.

[56] C. Ottone, B. Krusche, A. Whitby, et al., “Direct Cell-Cell Contact With the Vascular Niche Maintains Quiescent Neural Stem Cells,” Nature Cell Biology 16, no. 11 (2014): 1045–1056.

[57] H. Sakaguchi, T. Kadoshima, M. Soen, et al., “Generation of Functional Hippocampal Neurons From Self-Organizing Human Embryonic Stem Cell-Derived Dorsomedial Telencephalic Tissue,” Nature Communications 6 (2015): 8896.

[58] M. A. Lancaster, N. S. Corsini, S. Wolfinger, et al., “Guided Self-Organization and Cortical Plate Formation in Human Brain Organoids,” Nature Biotechnology 35, no. 7 (2017): 659–666.

[59] C. Martins-Costa, V. A. Pham, J. Sidhaye, et al., “Morphogenesis and Development of Human Telencephalic Organoids in the Absence and Presence of Exogenous Extracellular Matrix,” EMBO Journal 42, no. 22 (2023): e113213.

[60] Y. Shi, L. Sun, M. Wang, et al., “Vascularized Human Cortical Organoids (Vorganoids) Model Cortical Development In Vivo,” PLoS Biology 18, no. 5 (2020): e3000705.

[61] Y. Zhu, X. Zhang, L. Sun, Y. Wang, and Y. Zhao, “Engineering Human Brain Assembloids by Microfluidics,” Advanced Materials 35, no. 14 (2023): 2210083.

[62] R. A. Wimmer, A. Leopoldi, M. Aichinger, D. Kerjaschki, and J. M. Penninger, “Generation of Blood Vessel Organoids From Human Pluripotent Stem Cells,” Nature Protocols 14, no. 11 (2019): 3082–3100.

[63] M. Campisi, Y. Shin, T. Osaki, C. Hajal, V. Chiono, and R. D. Kamm, “3D Self-Organized Microvascular Model of the Human Blood-Brain Barrier With Endothelial Cells, Pericytes and Astrocytes,” Biomaterials 180 (2018): 117–129.

[64] Z. Gu, Q. Wu, B. Shang, K. Zhang, and W. Zhang, “Organoid Co-Culture Models of the Tumor Microenvironment Promote Precision Medicine,” Cancer Innovation 3, no. 1 (2024): e101.

[65] Y. Wei, H. Pan, J. Yang, C. Zeng, W. Wan, and S. Chen, “Aligned Cryogel Fibers Incorporated 3D Printed Scaffold Effectively Facilitates Bone Regeneration by Enhancing Cell Recruitment and Function,” Science Advances 10, no. 6 (2024): eadk6722.

[66] J. Ma, F. Yang, S. K. Both, et al., “In Vitro and In Vivo Angiogenic Capacity of BM-MSCs/HUVECs and AT-MSCs/HUVECs Cocultures,” Biofabrication 6, no. 1 (2014): 015005.

[67] S. S. Lee, J. H. Kim, J. Jeong, et al., “Sequential Growth Factor Releasing Double Cryogel System for Enhanced Bone Regeneration,” Biomaterials 257 (2020): 120223.

[68] S. S. Lee, N. Kleger, G. A. Kuhn, et al., “A 3D-Printed Assemblable Bespoke Scaffold as a Versatile Microcryogel Carrier for Site-Specific Regenerative Medicine,” Advanced Materials 35, no. 44 (2023): 2302008.

[69] S. S. Lee, M. Santschi, and S. J. Ferguson, “A Biomimetic Macroporous Hybrid Scaffold With Sustained Drug Delivery for Enhanced Bone Regeneration,” Biomacromolecules 22, no. 6 (2021): 2460–2471.

[70] I. Kim, S. S. Lee, S. Bae, H. Lee, and N. S. Hwang, “Heparin Functionalized Injectable Cryogel With Rapid Shape-Recovery Property for Neovascularization,” Biomacromolecules 19, no. 6 (2018): 2257–2269.

[71] D. S. Masson-Meyers, F. Tabatabaei, L. Steinhaus, J. M. Toth, and L. Tayebi, “Development of Fibroblast/Endothelial Cell-Seeded Collagen Scaffolds for In Vitro Prevascularization,” Journal of Biomedical Materials Research. Part B, Applied Biomaterials 111, no. 3 (2023): 633–645.

[72] I. Kim, S. S. Lee, S. H. L. Kim, S. Bae, H. Lee, and N. S. Hwang, “Osteogenic Effects of VEGF-Overexpressed Human Adipose-Derived Stem Cells With Whitlockite Reinforced Cryogel for Bone Regeneration,” Macromolecular Bioscience 19, no. 5 (2019): 1800460.

[73] S. Shafiee, S. Shariatzadeh, A. Zafari, A. Majd, and H. Niknejad, “Recent Advances on Cell-Based co-Culture Strategies for Prevascularization in Tissue Engineering,” Frontiers in Bioengineering and Biotechnology 9 (2021): 745314.

[74] R. Huang, F. Gao, L. Yu, H. Chen, and R. Zhu, “Generation of Neural Organoids and Their Application in Disease Modeling and Regenerative Medicine,” Advanced Science 12 (2025): e01198.

[75] Y. Shi, Q. Wu, and X. Wang, “Modeling Brain Development and Diseases With Human Cerebral Organoids,” Current Opinion in Neurobiology 66 (2021): 103–115.

[76] R. C. Janzer and M. C. Raff, “Astrocytes Induce Blood-Brain Barrier Properties in Endothelial Cells,” Nature 325, no. 6101 (1987): 253–257.

[77] A. Armulik, G. Genové, M. Mäe, et al., “Pericytes Regulate the Blood-Brain Barrier,” Nature 468, no. 7323 (2010): 557–561.

[78] N. Werschler, C. Quintard, S. Nguyen, and J. Penninger, “Engineering Next Generation Vascularized Organoids,” Atherosclerosis 398 (2024): 118529.

[79] S. Grebenyuk and A. Ranga, “Engineering Organoid Vascularization,” Frontiers in Bioengineering and Biotechnology 7 (2019): 39.

[80] A. Grath and G. Dai, “SOX17/ETV2 Improves the Direct Reprogramming of Adult Fibroblasts to Endothelial Cells,” Cell Reports Methods 4, no. 3 (2024): 100732.

[81] K. Lammerts van Bueren and B. L. Black, “Regulation of Endothelial and Hematopoietic Development by the ETS Transcription Factor Etv2,” Current Opinion in Hematology 19, no. 3 (2012): 199–205.

[82] I. Burtscher, W. Barkey, M. Schwarzfischer, F. J. Theis, and H. Lickert, “The Sox17-mCherry Fusion Mouse Line Allows Visualization of Endoderm and Vascular Endothelial Development,” Genesis 50, no. 6 (2012): 496–505.

[83] H. Zhou, X. Li, R. X. Wu, et al., “Periodontitis-Compromised Dental Pulp Stem Cells Secrete Extracellular Vesicles Carrying miRNA-378a Promote Local Angiogenesis by Targeting Sufu to Activate the Hedgehog/Gli1 Signalling,” Cell Proliferation 54, no. 5 (2021): e13026.

[84] S. Y. Oh, J. Y. Kim, and C. Park, “The ETS Factor, ETV2: A Master Regulator for Vascular Endothelial Cell Development,” Molecules and Cells 38, no. 12 (2015): 1029–1036.

[85] R. Tsaryk, N. Yucel, E. V. Leonard, et al., “Shear Stress Switches the Association of Endothelial Enhancers From ETV/ETS to KLF Transcription Factor Binding Sites,” Scientific Reports 12, no. 1 (2022): 4795.

[86] K. Wang, R.-Z. Lin, X. Hong, et al., “Robust Differentiation of Human Pluripotent Stem Cells Into Endothelial Cells via Temporal Modulation of ETV2 With Modified mRNA,” Science Advances 6, no. 30 (2020): eaba7606.

[87] J. Li, Y. Zhu, N. Li, et al., “Upregulation of ETV2 Expression Promotes Endothelial Differentiation of Human Dental Pulp Stem Cells,” Cell Transplantation 30 (2021): 0963689720978739.

[88] M. J. Workman, M. M. Mahe, S. Trisno, et al., “Engineered Human Pluripotent-Stem-Cell-Derived Intestinal Tissues With a Functional Enteric Nervous System,” Nature Medicine 23, no. 1 (2017): 49–59.

[89] N. D. Lawson, N. Scheer, and V. N. Pham, Notch Signaling is Required for Arterial-Venous Differentiation During Embryonic Vascular Development, 2001.

[90] X. Cui, Y. W. Lu, V. Lee, et al., “Venous Endothelial Marker COUP-TFII Regulates the Distinct Pathologic Potentials of Adult Arteries and Veins,” Scientific Reports 5, no. 1 (2015): 16193.

[91] J. Aitsebaomo, A. L. Portbury, J. C. Schisler, and C. Patterson, “Brothers and Sisters: Molecular Insights Into Arterial–Venous Heterogeneity,” Circulation Research 103, no. 9 (2008): 929–939.

[92] S. Arora, E. K. Yim, and Y.-C. Toh, “Environmental Specification of Pluripotent Stem Cell Derived Endothelial Cells Toward Arterial and Venous Subtypes,” Frontiers in Bioengineering and Biotechnology 7 (2019): 143.

[93] Y. Huang, X. Chen, J. Che, Q. Zhan, J. Ji, and Y. Fan, “Shear Stress Promotes Arterial Endothelium-Oriented Differentiation of Mouse-Induced Pluripotent Stem Cells,” Stem Cells International 2019, no. 1 (2019): 1847098.

[94] I. Salmon, S. Grebenyuk, A. R. Abdel Fattah, et al., “Engineering Neurovascular Organoids With 3D Printed Microfluidic Chips,” Lab on a Chip 22, no. 8 (2022): 1615–1629.

[95] P. Avena, L. Zavaglia, I. Casaburi, and V. Pezzi, “Perfusion Bioreactor Technology for Organoid and Tissue Culture: A Mini Review,” Oncologist 5, no. 2 (2025): 17.

[96] W. Schachterle, C. R. Badwe, B. Palikuqi, et al., “Sox17 Drives Functional Engraftment of Endothelium Converted From Non-Vascular Cells,” Nature Communications 8, no. 1 (2017): 13963.

[97] H. Castiglione, P. A. Vigneron, C. Baquerre, F. Yates, J. Rontard, and T. Honegger, “Human Brain Organoids-On-Chip: Advances, Challenges, and Perspectives for Preclinical Applications,” Pharmaceutics 14, no. 11 (2022): 2301.

[98] Z. Li, D. Yu, C. Zhou, et al., “Engineering Vascularised Organoid-On-a-Chip: Strategies, Advances and Future Perspectives,” Biomaterials Translational 5, no. 1 (2024): 21–32.

[99] H. Zhang, N. Huang, S. Bian, and M. Sawan, “Brain Organoids-On-Chip for Neural Diseases Modeling: History, Challenges and Trends,” Journal of Pharmaceutical Analysis 15 (2025): 101323.

[100] H. Liu, X. Zhang, J. Liu, and J. Qin, “Vascularization of Engineered Organoids,” BME Mater 1, no. 3 (2023): e12031.

[101] A.-N. Cho, Y. Jin, Y. An, et al., “Microfluidic Device With Brain Extracellular Matrix Promotes Structural and Functional Maturation of Human Brain Organoids,” Nature Communications 12, no. 1 (2021): 4730.

[102] Y. Wang, L. Wang, Y. Zhu, and J. Qin, “Human Brain Organoid-On-a-Chip to Model Prenatal Nicotine Exposure,” Lab on a Chip 18, no. 6 (2018): 851–860.

[103] B. Ye, “Approaches to Vascularizing Human Brain Organoids,” PLoS Biology 21, no. 5 (2023): e3002141.

[104] M. T. Rogers, A. L. Gard, R. Gaibler, et al., “A High-Throughput Microfluidic Bilayer Co-Culture Platform to Study Endothelial-Pericyte Interactions,” Scientific Reports 11, no. 1 (2021): 12225.

[105] Q. Shen, S. K. Goderie, L. Jin, et al., “Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells,” Science 304, no. 5675 (2004): 1338–1340.

[106] X. Yin, B. E. Mead, H. Safaee, R. Langer, J. M. Karp, and O. Levy, “Engineering Stem Cell Organoids,” Cell Stem Cell 18, no. 1 (2016): 25–38.

[107] Q. Gao, J. Wang, H. Zhang, J. Wang, Y. Jing, and J. Su, “Organoid Vascularization: Strategies and Applications,” Advanced Healthcare Materials 14 (2025): 2500301.

[108] X.-Y. Sun, X.-C. Ju, Y. Li, et al., “Generation of Vascularized Brain Organoids to Study Neurovascular Interactions,” eLife 11 (2022): e76707.

[109] M. G. Kook, S.-E. Lee, N. Shin, et al., “Generation of Cortical Brain Organoid With Vascularization by Assembling With Vascular Spheroid,” International Journal of Stem Cells 15, no. 1 (2022): 85–94.

[110] E. LaMontagne, A. R. Muotri, and A. J. Engler, “Recent Advancements and Future Requirements in Vascularization of Cortical Organoids,” Frontiers in Bioengineering and Biotechnology 10 (2022): 1048731.

[111] X. Y. Sun, X. C. Ju, H. F. Zhao, Z. W. You, R. R. Han, and Z. G. Luo, “Generation of Human Blood Vessel and Vascularized Cerebral Organoids,” Bio-Protocol 13, no. 21 (2023): e4870.

[112] Y. Li, X. Y. Sun, P. M. Zeng, and Z. G. Luo, “Neural Responses to Hypoxic Injury in a Vascularized Cerebral Organoid Model,” Neuroscience Bulletin 41 (2025): 1779–1791.

[113] W. Zhu, Y. Wu, X. Li, et al., “A Stroke Organoids-Multiomics Platform to Study Injury Mechanism and Drug Response,” Bioactive Materials 44 (2025): 68–81.

[114] Y. Ji, X. Chen, Z. Wang, et al., “Alzheimer's Disease Patient Brain Extracts Induce Multiple Pathologies in Novel Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery,” Molecular Psychiatry 30 (2025): 4558–4575.

[115] L. Papamichail, L. S. Koch, D. Veerman, K. Broersen, and A. D. van der Meer, “Organoids-On-a-Chip: Microfluidic Technology Enables Culture of Organoids With Enhanced Tissue Function and Potential for Disease Modeling,” Frontiers in Bioengineering and Biotechnology 13 (2025): 1515340.

[116] X.-Y. Sun and Z.-G. Luo, “Vascularizing the Brain Organoids,” Journal of Molecular Cell Biology 14, no. 6 (2022): mjac040.

[117] L. O'Halloran, O. Akinsete, A. L. Kogan, M. Wrona, and A. F. Mahdi, “3D In Vitro Blood–Brain Barrier Models: Recent Advances and Their Role in Brain Disease Research and Therapy,” Frontiers in Pharmacology 16 (2025): 1637602.

[118] C. Giorgi, G. Lombardozzi, F. Ammannito, et al., “Brain Organoids: A Game-Changer for Drug Testing,” Pharmaceutics 16, no. 4 (2024): 443.

[119] C. F. Cho, J. M. Wolfe, C. M. Fadzen, et al., “Blood-Brain-Barrier Spheroids as an In Vitro Screening Platform for Brain-Penetrating Agents,” Nature Communications 8 (2017): 15623.

[120] L. Dao, Z. You, L. Lu, et al., “Modeling Blood-Brain Barrier Formation and Cerebral Cavernous Malformations in Human PSC-Derived Organoids,” Cell Stem Cell 31, no. 6 (2024): 818–833.e811.

[121] V. Sokolova, G. Mekky, S. B. van der Meer, M. C. Seeds, A. J. Atala, and M. Epple, “Transport of Ultrasmall Gold Nanoparticles (2 Nm) Across the Blood–Brain Barrier in a Six-Cell Brain Spheroid Model,” Scientific Reports 10, no. 1 (2020): 18033.

[122] W. J. Kowalski, S. Vatti, T. Sakamoto, et al., “In Vivo Transplantation of Mammalian Vascular Organoids Onto the Chick Chorioallantoic Membrane Reveals the Formation of a Hierarchical Vascular Network,” Scientific Reports 15, no. 1 (2025): 7150.

[123] S.-Y. Cao, D. Yang, Z.-Q. Huang, et al., “Cerebral Organoids Transplantation Repairs Infarcted Cortex and Restores Impaired Function After Stroke,” npj Regenerative Medicine 8, no. 1 (2023): 27.

[124] J.-T. Kim, T. Y. Kim, D. H. Youn, et al., “Human Embryonic Stem Cell-Derived Cerebral Organoids for Treatment of Mild Traumatic Brain Injury in a Mouse Model,” Biochemical and Biophysical Research Communications 635 (2022): 169–178.

[125] C.-L. Fu, B.-C. Dong, X. Jiang, D. Li, and J. Yao, “A Cell Therapy Approach Based on iPSC-Derived Midbrain Organoids for the Restoration of Motor Function in a Parkinson's Disease Mouse Model,” Heliyon 10, no. 2 (2024): e24234.

[126] H. H. Zhao and G. Haddad, “Brain Organoid Protocols and Limitations,” Frontiers in Cellular Neuroscience 18 (2024): 1351734.

[127] S. O. Sandoval, G. Cappuccio, K. Kruth, et al., “Rigor and Reproducibility in Human Brain Organoid Research: Where We Are and Where We Need to Go,” Stem Cell Reports 19, no. 6 (2024): 796–816.

[128] N. Urrestizala-Arenaza, S. Cerchio, F. Cavaliere, and C. Magliaro, “Limitations of Human Brain Organoids to Study Neurodegenerative Diseases: A Manual to Survive,” Frontiers in Cellular Neuroscience 18 (2024): 1419526.

[129] A. O. Ajongbolo and S. A. Langhans, “Brain Organoids and Assembloids—From Disease Modeling to Drug Discovery,” Cells 14, no. 11 (2025): 842.

[130] S. S. Lee, S. Huber, and S. J. Ferguson, “Comprehensive In Vitro Comparison of Cellular and Osteogenic Response to Alternative Biomaterials for Spinal Implants,” Materials Science and Engineering: C 127 (2021): 112251.

[131] S. S. Lee, L. Laganenka, X. Du, W.-D. Hardt, and S. J. Ferguson, “Silicon Nitride, a Bioceramic for Bone Tissue Engineering: A Reinforced Cryogel System With Antibiofilm and Osteogenic Effects,” Frontiers in Bioengineering and Biotechnology 9 (2021): 9.

[132] I. Hyun, “Ethical Considerations for Human-Animal Neurological Chimera Research: Mouse Models and Beyond,” EMBO Journal 38, no. 21 (2019): e103331.

[133] Y. Gong, Z. Zhou, T. Xu, et al., “Padlock-Designed MOFs Triggers an “Avalanche Effect” to Enhance Apoptosis and Suppress Metastasis in Central Nervous System Lymphoma,” Science Advances 11, no. 40 (2025): eadv2647.

[134] Z. Zhang, X. Zhou, Y. Fang, Z. Xiong, and T. Zhang, “AI-Driven 3D Bioprinting for Regenerative Medicine: From Bench to Bedside,” Bioactive Materials 45 (2025): 201–230.

[135] M. Gharibshahian, M. Torkashvand, M. Bavisi, N. Aldaghi, and A. Alizadeh, “Recent Advances in Artificial Intelligent Strategies for Tissue Engineering and Regenerative Medicine,” Skin Research and Technology 30, no. 9 (2024): e70016.

RIGHTS & PERMISSIONS

2026 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.